Han, Yongsheng (2023): Changes in anti-tumor immune response after resection of hepatocellular carcinoma. Dissertation, LMU München: Medizinische Fakultät
Li, Qian (2022): Role of muscarinic signalling in pancreatic cancer. Dissertation, LMU München: Medizinische Fakultät
Li, Xiaokang (2022): Establishment of a co-culture system to study the interactions between major immune effector cells and hepatocellular carcinoma. Dissertation, LMU München: Medizinische Fakultät
Zhang, Tao (2022): Quantification of the Tumor immune Stroma (QTiS) and the metabolic checkpoint molecules in pancreatic cancer: comparison between primary and metastatic tumor. Dissertation, LMU München: Medizinische Fakultät
Li, Xinyu (2021): Cancer stem-like cells in hepatocellular carcinoma. Dissertation, LMU München: Medizinische Fakultät
Zhang, Chun (2021): The vitamin D analogue calcipotriol attenuates pancreatic cancer malignancy via downregulating thrombospondin 1 in pancreatic stellate cells. Dissertation, LMU München: Medizinische Fakultät
Kripp, Hemma (2021): Etablierung eines Spender-spezifischen IgG ELISpots zum Immunomonitoring nach Transplantation. Dissertation, LMU München: Medizinische Fakultät
Wu, Yang (2021): Role of VDR in stellate cells activation and tumor-stroma crosstalk in pancreatic cancer. Dissertation, LMU München: Medizinische Fakultät
Härtwig, Daniel (2019): Die Rolle von LGR6 in der Genese des humanen duktalen Pankreaskarzinoms (PDAC). Dissertation, LMU München: Medizinische Fakultät
Wang, Jing (2019): Deciphering the roles of LGR6 in WNT and EMT signaling in pancreatic cancer. Dissertation, LMU München: Medizinische Fakultät
Yin, Shuai (2018): Targeting retinoid receptors with dysregulated microNRAs in pancreatic duct adenocarcinoma. Dissertation, LMU München: Medizinische Fakultät
Hao, Jingcheng (2018): Influence of perivascular tumor infiltrating leukocytes on survival after resection of early hepatocellular carcinoma. Dissertation, LMU München: Medizinische Fakultät